Advanced search
Instruments
| Name | Stock exchange | Average volume | Price | Type | ||
|---|---|---|---|---|---|---|
| HANG LUNG GROUP LIMITED | 10 | Hong Kong S.E. +4 Other | 2,321,701 |
8.78
HKD
 | Stock | |
| HANG LUNG GROUP LIMITED | HLU | Deutsche Boerse AG | - |
1.01
EUR
| ||
| HANG LUNG GROUP LIMITED | HLU | Börse Stuttgart | - |
1.02
EUR
| ||
| HANG LUNG GROUP LIMITED | HNLGF | OTC Markets | 0 |
1.18
USD
| ||
| HANG LUNG GROUP LIMITED | HLU | Berne S.E. | - | - CHF
| ||
| HANG LUNG PROPERTIES LIMITED | 101 | Hong Kong S.E. +5 Other | 36,551,535 |
7.3
HKD
| Stock | |
| HANG LUNG PROPERTIES LIMITED | AOP | Deutsche Boerse AG | - |
0.835
EUR
| ||
| HANG LUNG PROPERTIES LIMITED | AOP | Börse Stuttgart | - |
0.82
EUR
| ||
| HANG LUNG PROPERTIES LIMITED | AOP | BOERSE MUENCHEN | - |
0.87
EUR
| ||
| HANG LUNG PROPERTIES LIMITED | HLPPF | OTC Markets | 98,172 |
0.9321
USD
| ||
| HANG LUNG PROPERTIES LIMITED | AOP | Berne S.E. | - | - CHF
| ||
| LUNG KEE (BERMUDA) HOLDINGS LIMITED | 255 | Hong Kong S.E. | 13,844 |
1.35
HKD
| Stock | |
| HON KWOK LAND INVESTMENT COMPANY, LIMITED | 160 | Hong Kong S.E. | - |
1.65
HKD
| Stock | |
| KWONG LUNG ENTERPRISE CO., LTD. | 8916 | Taipei Exchange | 164,753 |
60.5
TWD
| Stock | |
| LUNG HWA ELECTRONICS CO., LTD. | 2424 | Taiwan S.E. | 37,164 |
30.15
TWD
| Stock | |
| LUNG PIEN VACUUM INDUSTRY CO., LTD. | 5267 | Taipei Exchange | 6,426 |
37.7
TWD
| Stock | |
| LUNG MING GREEN ENERGY TECHNOLOGY ENGINEERING CO., LTD. | 3018 | Taiwan S.E. | 35,969 |
15.55
TWD
| Stock | |
| HANG LUNG PROPERTIES LIMITED | HLPPY | OTC Markets +1 Other | 282,243 |
4.56
USD
| Stock | |
| HANG LUNG PROPERTIES LIMITED | AOP0 | BOERSE MUENCHEN | - |
4.4
EUR
| ||
| HANG LUNG GROUP LIMITED | HNLGY | OTC Markets | 72 |
5.575
USD
| Stock |
News (98)
Companies (178)
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (neb ...
Hon Kwok Land Investment Company, Limited is a Hong Kong-based investment holding company principally engaged in property businesses. The Company operates through three segments. The Property Development segment is engaged in property development. The Pro ...
Insmed Incorporated is a global biopharmaceutical company. The Company's first commercial product, ARIKAYCE (amikacin liposome inhalation suspension), is used for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination ant ...
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), refe ...
bioAffinity Technologies, Inc. is a biotechnology company focused on commercializing noninvasive tests for the detection of early-stage cancer and lung disease. The Company addresses the need for noninvasive diagnosis of early-stage cancer and diseases of ...
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bi ...
Innovent Biologics Inc is an investment holding company principally engaged in biopharmaceuticals. The Company and its subsidiaries are engaged in research and development of antibody and protein medicine products, sale and distribution of pharmaceutical ...
Biodesix, Inc. (Biodesix) is a diagnostic solutions and services company. The Company develops diagnostic tests addressing clinical questions by combining multi-omics through the power of artificial intelligence. Biodesix offers over five Medicare-covered ...
Neola Medical AB, formerly GPX Medical AB is a Sweden-based company that is involved in development of medical instruments. The Company's business concept is to commercialize the Company's medical technology product for continuous lung monitoring based on ...
Broncus Holding Corp is a China-based investment holding company providing innovative solutions for lung diseases. The Company's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solut ...
ImmunoGen, Inc. is a commercial-stage biotechnology company. The Company is focused on developing and commercializing of antibody- drug conjugates (ADCs) to improve outcomes for cancer patients. An ADC with the Company's technology comprises an antibody t ...
Synairgen plc is a United Kingdom-based holding company for Synairgen Research Limited, which is a respiratory drug discovery and development company. The Company is developing SNG001, an investigative formulation of inhaled interferon beta (IFN-B), for t ...
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions i ...
Blueprint Medicines Corporation is a global precision therapy company that is inventing life-changing medicines in two areas of allergy/inflammation and oncology/hematology. The Company delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritin ...
MannKind Corporation is a biopharmaceutical company. It is focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. Its technologies include Technosphere dry-powder formulations ...
Tiansheng Pharmaceutical Group Co LTD is a China-based company principally engaged in the research and development, manufacture and sales of pharmaceuticals. The Company's main products include pediatric lung cough particles, erythromycin enteric-coated c ...
4DMedical Limited is an Australia-based medical technology company. Through its flagship patented XV Technology, the Company enables physicians to understand regional airflow in the lungs and identify respiratory deficiencies earlier and with greater sens ...
Cizzle Biotechnology Holdings Plc is a United Kingdom-based diagnostics development company. The Company is engaged in the development of a blood test for the early detection of lung cancer. Its prototype test is based on the ability to detect a stable pl ...
Cizzle Biotechnology Holdings Plc is a United Kingdom-based diagnostics development company. The Company is engaged in the development of a blood test for the early detection of lung cancer. Its prototype test is based on the ability to detect a stable pl ...
LungLife AI, Inc. is a developer of clinical diagnostic solutions for lung cancer. The Company is engaged in the development and commercialization of its lung cancer early detection test. Using a minimally invasive blood draw, its LungLB test is designed ...
Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. The Companyâs LungFit platfo ...
Antengene Corporation Limited is a clinical-stage Asia-Pacific biopharmaceutical company focused on innovative oncology medicines. The Company is principally engaged in the discovery, development, manufacturing and commercialization of biotech products. T ...
BibbInstruments AB is a Sweden-based medical technology company. It develops and sales biopsy instruments, which are based on technology platform EndoDrill. The drill function enables early cancer diagnosis, especially in deep skin tissues. The portfolio ...
Amoy Diagnostics Co Ltd is a pharmaceutical company engaged in research, development, production and sales of molecular diagnostic products. The Company provides testing reagents and testing services for tumor diagnosis. The Companyâs testing reagent pr ...
Gyre Therapeutics, Inc. is a biotechnology company. The Company is engaged in the research, development, manufacturing and commercialization of drugs for organ fibrosis. It is primarily focused on the development and commercialization of Hydronidone (F351 ...
Galera Therapeutics, Inc. is a biopharmaceutical company focused on developing a pipeline of novel, therapeutic candidates that have the potential to transform radiotherapy in cancer. The Companyâs lead product candidate, avasopasem manganese (avasopase ...
Y Biologics Inc is a Korea-based company principally engaged in the new drug development business. The Company is principally engaged in the research and development of new cancer antibody drugs for small cell lung cancer, liver cancer, solid cancer as we ...
4D Molecular Therapeutics, Inc. is a clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat diseases in ophthalmology and pulmonology. The Company has a portfolio of genetic medicine product candidat ...
Liquidia Corporation is a biopharmaceutical company. The Company is focused on the development, manufacture and commercialization of products that address unmet patient needs, with a focus directed towards rare cardiopulmonary diseases, such as pulmonarya ...
Prime Medicine, Inc. is a biotechnology company engaged in creating and delivering the gene editing therapies to patients. It deploys its Prime Editing platform, a gene editing technology, to develop a new class of differentiated, one-time genetic therapi ...
AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. Its initial candidate is epetraborole, which is a potential onc ...
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development ...
EV Minerals Corporation is a Canadian exploration company focused on mineral exploration and development. The Company focuses on the EV Nickel Project, the host of the nickel-copper-cobalt deposit. The Project comprises approximately 32 mineral claims cov ...
Pulmatrix, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of novel inhaled therapeutic products intended to prevent and treat respiratory and other diseases with important unmet medical needs using its patent ...
Inhibitor Therapeutics, Inc. is a pharmaceutical development company. The Company is focused on developing and commercializing therapeutics based on already approved active pharmaceuticals that have patent-protected methods of use and/or methods of delive ...
Aerovate Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, its dry powde ...
Theravance Biopharma, Inc. is a biopharmaceutical company primarily focused on the development, and commercialization of medicines. Its product, YUPELRI (revefenacin) inhalation solution is indicated for the maintenance treatment of patients with chronic ...
Savara Inc. is a clinical-stage biopharmaceutical company, which is focused on rare respiratory diseases. The Companyâs lead program, molgramostim nebulizer solution (molgramostim), is an inhaled biologic, specifically an inhaled granulocyte-macrophage ...
Aceragen Inc is a clinical-stage biopharmaceutical company. The Company is focused on the clinical development, and commercialization, of drug candidates for rare disease indications characterized by small, well-defined patient populations with serious un ...
Lung Kee Bermuda Holdings Ltd is an investment holding company principally engaged in the mould base business. The Company is engaged in the manufacture and sale of mould bases and related products. The Company sells its products in China, America, Europe ...
Belluscura PLC is a United Kingdom-based medical device developer company. The Company is focused on developing lightweight and portable oxygen enrichment technology. The Company's product X-PLOR, is a modular portable oxygen concentrator. The X-PLOR is l ...
Monte Rosa Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing a portfolio of novel and molecular glue degraders (MGDs) for patients living with serious diseases in the areas of oncology and autoimmune, and m ...
Incannex Healthcare Inc. is a clinical-stage pharmaceutical development company. The Company is developing medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for the treatment of obstructive sleep apnea (OSA), traumatic brain ...
NovoCure Limited is a global oncology company. The Company is engaged in the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune and Optune Lua for the treatment of solid tumor cancers. Its commerci ...
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The Company offers testing servi ...
BioAdaptives, Inc. manufactures and distributes natural plant and algal-based products that improve health and wellness for humans and animals, with an emphasis on optimizing pain relief, antiviral activity, and immune system defense; resistance to stress ...
aTyr Pharma, Inc. is a clinical-stage biotechnology company. The Company is leveraging intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. Its lead therapeutic candidate is efzofitimod, a biologic immunomodu ...
Arch Biopartners Inc. is a portfolio-based biotechnology company focused on the development of technologies that have the potential to make a medical or commercial impact. The Company is focused on the clinical development of its drug platform in targetin ...
Bridge Biotherapeutics, Inc. is a Korea-based company principally engaged in the research and development of bio therapeutic drugs. The products mainly consist of ulcerative colitis medicine BBT-401, autoxin inhibitor BBT-877, non-small cell lung cancer m ...
Aptamer Sciences Inc is a Korea-based company principally engaged in the research and development of bio therapeutic drugs. The Company provides services include aptamer synthesis and aptamer discovery. The Company also develops biopharmaceuticals such as ...
Kai BioTech Co Ltd is a Korea-based company mainly engaged in the medical business based on radioactive fusion technology. The Company is engaged in the manufacture and sale of radiopharmaceuticals used in the diagnosis of oncology, prostate, liver, lung ...
AdAlta Limited is an Australia-based clinical-stage drug discovery company. The Company is engaged in the development of therapeutic products from its i-body platform. The Company has five active development programs ranging from discovery to Phase II cli ...
Genprex, Inc. is a clinical-stage gene therapy company focused on developing therapies for patients with cancer and diabetes. The Companyâs technologies are designed to administer disease-fighting genes to provide new therapies for large patient populat ...
Nuvalent, Inc. is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer. It develops small molecules that have the potential to overcome resistance, minimize adverse even ...
MedPacto, Inc. is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as t ...
Tellgen Corp is a company engaged in research, development, production and sales of in vitro diagnostic reagents and instruments. The Company's products are comprised of immunodiagnostic products, molecular diagnostic products and biochemical diagnostic p ...
Betta Pharmaceuticals Co Ltd is a company mainly engaged in research, development, production and sales of innovative drugs for the treatment of malignant tumors. The Company's primary product is its self-developed icotinib hydrochloride (Conmana), a smal ...
Gencurix Inc. is a Korea-based company mainly engaged in the sale of medical equipments. In addition, the Company is involved in the manufacturing and sale of breast cancer test (BCT) kits, Korean genetic polymorphism diagnostic kits, lung cancer and colo ...
Lung Hwa Electronics Co., Ltd. is a Taiwan-based company principally engaged in the design, manufacture, processing and distribution of system hosts. The Company mainly provides intelligent home portal security control systems, vehicle multimedia manageme ...
Kwong Lung Enterprise Co., Ltd. is a Taiwan-based company principally engaged in the cleaning and processing of down materials, as well as the processing of garments. The company is also engaged in the manufacture and sales of feather bedding and home tex ...
PExA AB is a Sweden-based company engaged in the advanced equipment and technology industry. The Company develops, manufactures and markets a non-invasive research instrument to study respiratory diseases, such as asthma and chronic obstructive pulmonary ...
Hang Lung Properties Limited specializes in promoting and managing real estate assets. The activity is organized around two areas: - real estate leasing; - sale of real estate assets: residential buildings, businesses, offices, hotels, industrial build ...
Pharmosa Biopharm Inc is a Taiwan-based company mainly engaged in the research and development of new drugs. The main products include L606, for the treatment of Category I pulmonary arterial hypertension (PAH); L606, for the treatment of Category III pul ...
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd, formerly Sichuan Kelun Biotech Biopharmaceutical Co Ltd, is a China-based company mainly engaged in the research and development, production, and sales of drugs. The Company is mainly engaged in the research ...
Shanghai Yizhong Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development and industrialization of new and improved anti-tumor drugs. The Company's main products include paclitaxel micelles, docetaxel micelles and ...
Hang Lung Group Ltd is an investment holding company principally engaged in the property leasing business. The Company operates its business through two segments. The Property Leasing segments engages in the property leasing operation. The Companyâs inv ...
FutureChem. Co.,Ltd is a Korea-based company principally engaged in the manufacture and distribution of radiopharmaceuticals. The Company manufactures radiopharmaceuticals including radiopharmaceuticals for diagnosis of various cancers such as lung cancer ...
LUNG PIEN VACUUM INDUSTRY CO., LTD. is a Taiwan-based company principally engaged in the manufacture and distribution of photoelectrical machinery. The Company is primarily involved in the provision of optical film coating machines, decorative film coatin ...
OBI Pharma, Inc. is a Taiwan-based company principally engaged in the development of new pharmaceuticals. The Company mainly operates its businesses through the research and development of novel cancer and infectious disease therapies. It also develops ne ...
Merus NV is the Netherlands - based biotechnology company, concentrated on developing differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Multiclonics format. Its products are designed to bind to m ...
Shouyao Holdings Co Ltd is a China-based company mainly engaged in the research and development of innovative drugs. The Company's main business is the research and development of small molecule innovative drugs in the clinical stage. The Company's main p ...
Gongwin Biopharm Holdings Co Ltd is a company engaged in the research and development of anti-cancer medicine, especially focuses on the precise treatment to tumors. The Companyâs headquarter is located in Taiwan and it created a cross-regional platform ...
Urteste SA is a Poland-based company mainly engaged in the biotechnology sector. The Company operates in the field of medical devices for in vitro application in the field of cancer diagnostics. The technology developed by the Company involves the detecti ...
Golden Biotechnology Corp is a Taiwan-based company mainly engaged in the development of new anti-cancer drugs. The Company's main development projects are novel compounds of Antroquinonol for the treatment of non-small cell lung cancer, acute myeloid leu ...
Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technolog ...
Oryzon Genomics SA, is a Spain-based clinical phase biopharmaceutical company, which discovers and develops drugs based on epigenetics for the treatment of oncological and neurological diseases. Its compounds in clinical development include iadademstat (O ...
Epigenomics AG is a Germany-based molecular diagnostics company focused on blood-based detection, prognosis and monitoring of cancers using deoxyribonucleic acid (DNA) methylation technology. It develops and commercializes blood-based diagnostic products ...
Genomictree Inc. is a Korea-based company mainly engaged in the genomic analysis. The Company is involved in conducting of genomic analysis using microarrays and next generation sequencing analysis. In addition, the Company is conducting clinical trials f ...
Original BioMedicals Co Ltd is a Taiwan-based company mainly engaged in the development of new drugs with non-new ingredients, and the provision of related research and development services, especially focusing on drugs with new dosage forms, new dosages, ...
Oncology Pharma, Inc. is an oncology company. The Company is focused on licensing, developing, manufacturing and commercializing therapeutics. The Companyâs research, development, and commercialization of therapeutic drugs and medical devices designed f ...
Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based company mainly engaged in the production, sales and service of chemical raw materials and intermediates. The Company is committed to providing one-stop customized pharmaceutical contract development ...
PT Royal Prima Tbk is an Indonesia-based healthcare services company. The Company provides hospital services, clinics, polyclinics and related business activities. The Company operates Royal Prima Medan and Royal Prima Jamb hospital. The Company provides ...
Shanghai Allist Pharmaceuticals Co Ltd is a China-based company focusing on the field of tumor treatment. The Company has built a research and development pipeline in the field of small molecule targeted drugs for non-small cell lung cancer. The Company h ...
FluoGuide A/S is a Denmark-based biotechnology company focused on developing drugs for maximizing surgical outcomes by making cancer fluorescent. The Company is a provider of solutions for maximizing surgical outcome through intelligent targeting. FluoGui ...
Nascent Biotech, Inc. is a phase II clinical-stage biopharmaceutical company engaged in developing monoclonal antibodies for the treatment of various cancer types. The Company focuses on biologic drug candidates that are undergoing or have already complet ...
Beta Drugs Limited is an India-based company, which is engaged in manufacturing of the wide range of anti-cancer drugs in India. The Company operates through manufacturing of Oncology medicines segment. The Company offers a portfolio consisting of approxi ...
Delta-Fly Pharma, Inc. is a Japan-based company principally engaged in the research, development, manufacture and sale of pharmaceuticals. The Company's development pipeline includes anticancer drug candidate compound DFP-10917 whose target disease is ref ...
Amniotics AB (publ) is a Sweden-based biotech company that develops cell therapy drugs based on mesenchymal stem cells from amniotic fluid in its in-house GMP licensed facility. Amniotics' own marker technology is used to identify and select stem cells fo ...
Hainan Huluwa Pharmaceutical Group Co Ltd is a China-based company principally involved in the research and development, manufacturing and sales of Chinese patent medicines and chemical drugs. Its products are used in the pharmaceutical fields of respirat ...
Inhalation Sciences Sweden AB is a Sweden-based company, which develops and sells labtech equipment for inhalation research. The Companyâs primary product is PreciseInhale, which is a laboratory system that lets scientists measure how inhaled particles ...
Spexis AG, former Polyphor AG, is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of first-in-class molecules in oncology and antimicrobial resistance leveraging its macrocyclic peptide te ...
Artemis Medicare Services Ltd, also known as Artemis Hospitals, is an India-based company, which operates a multi-specialty hospital. The Company is specializes in a range of advanced medical and surgical interventions, a mix of inpatient and outpatient s ...
Nextage Therapeutics Ltd, formerly known asMicromedic Technologies Ltd,is an Israel-based company engaged in the development and commercialization of cancer diagnostic products. Its portfolio includes a range of cancer and cancer-related indications inclu ...
Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing transformative therapies for rare and neurological diseases with limited treatment options. The Companyâs Trappsol Cyclo is a proprietary formulatio ...
Alteco Medical AB is a Sweden-based company engaged in the healthcare and biotechnology business sector. The Company develops medical devices focusing on intensive care. The Companyâs product named Alteco LPS Adsorber is used within the sepsis area and ...
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is e ...
Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. The Company operates in two segments: Durable goods and Non-Durable goods ...
Clinical Laserthermia Systems AB is a Sweden-based company active in the medical equipment industry. The Company develops and markets a product for the treatment of solid cancer tumors. The product is based on Immunostimulating Laser Thermo Therapy (imILT ...
NGeneBio Co Ltd is a Korea-based company engaged in the manufacture and sale of precision diagnostic products. The Company's main products include BRCAaccuTest products used for hereditary breast and ovarian cancer testing, HEMEaccuTest products that test ...
Rosetta Genomics Ltd. is an Israel-based company engaged in developing and commercializing new diagnostic tests based on various genomics markers, including deoxyribonucleic acid (DNA), micro ribonucleic acid (microRNA), and protein biomarkers, and using ...
Insiders
Kwok Lung Hongchoy is currently the Chief Executive Officer & Executive Director at Link Real Estate Investment Trust since 2010 and at Link Asset Management Ltd.
since 2009.
He is also a Director at Link Properties Ltd.
and a Trustee at the University of Pennsylvania.
Additionally, he serves as a Member-Supervisory Board at Tracker Fund of Hong Kong and as an Adjunct Professor at the University of Hong Kong since 2020.
Mr. Hongchoy is a Member of the Hong Kong Institute of Certified Public Accountants, the New Zealand Institute of Chartered Accountants, the Royal Institution of Chartered Surveyors, the Hong Kong Securities & Investment Institute, the Hong Kong Institute of Directors, the Institute of Shopping Centre Management, the Wharton School of the University of Pennsylvania's Asia Executive Board, and Chartered Accountants Australia & New Zealand.
Formerly, Mr. Hongchoy held positions as the Managing Director-Investment Banking at NM Rothschild & Sons (Hong Kong) Ltd., the Managing Director at DBS Asia Capital Ltd., and as a Director at Link Holdings Ltd.
He also served as a Director at the Asian Public Real Estate Association Ltd., Rishon Finance Ltd., Hong Kong Cyberport Management Co. Ltd., and the Hong Kong Applied Science & Technology Research Institute.
Additionally, he was a Professor at the Hong Kong Polytechnic University and a Trustee at the Urban Land Institute.
Mr. Hongchoy was also a Governor at the Forum Mondial de L'Economie.
In terms of education, Mr. Hongchoy completed his undergraduate studies at the University of Canterbury and holds an MBA from The Wharton School of the University of Pennsylvania.
Ms. Won Lung is a Chief Compliance Officer at Intercorp Financial Services, Inc. and a Chief Compliance Officer at Banco Internacional del Perú SAA Interbank. Ms. Lung was previously employed as a Principal-General Security by BNP Paribas Investment Services LLC and a Vice President & Project Manager by Suntrust Bank /Fl/. She received her undergraduate degree from Florida International University and an MBA from Nova Southeastern University, Inc..
Jung Lung Hou is currently a Director at President International Development Corp.
Prior to his current position, he worked as a Non-Executive Director at Uni-President China Holdings Ltd.
from 2011 to 2017 and as a General Manager at Uni-President Enterprises Corp.
from 2016 to 2019.
He also held positions as Deputy General Manager & Head-Sales Department at Kirin Brewery (Zhuhai) Co. Ltd., Manager at Guangzhou President Enterprises Co., Ltd., General Manager & Head-Human Resources at Uni-President Enterprises (China) Investment Co., Ltd., and General Manager at Beijing President Enterprises Drinks & Food Co., Ltd.
Mr. Hou holds an MBA from Tsinghua University.
Fei Lung Kuo is on the board of Accton Technology (China) Co. Ltd. and Waveline Technologies Co., Ltd. and Chairman for Accton Technology Corp. He received an MBA from Saginaw Valley State University (Michigan).
Wei Lung Liau is Senior Deputy General Manager at AU Optronics Corp.
Cheng Lung Hu is on the board of Everest Textile Co., Ltd. and Far Eastern Apparel Co. Ltd. and General Manager-Textile at Far Eastern New Century Corp. Mr. Hu received an undergraduate degree from Tunghai University.
Fu Lung Hsieh occupies the position of General Manager for Wan Hai Lines Ltd. and Chairman of Wan Hai Lines Vietnam Ltd. (a subsidiary of Wan Hai Lines Ltd.). He is also on the board of 7 other companies. He received an undergraduate degree from National Taiwan Ocean University.
Chin Lung Hsiao is Senior Vice President-Operation Management at EVA Airways Corp.
Kwok Keung Lee is a professional with an MBA from the University of Hong Kong and an undergraduate degree from The Chinese University of Hong Kong.
He is currently a Member-Banking & Finance Industry Training at Vocational Training Council.
Previously, he held the position of Chief Executive Officer at The Stock Exchange of Hong Kong Ltd.
and Hong Kong Futures Exchange Ltd.
He also served as Joint Chief Operating Officer at Hong Kong Exchanges & Clearing Ltd.
from 2017 to 2019.
Kwok Keung Cheung is Managing Director & Executive Director at Kingboard Laminates Holdings Ltd.
Kai-chun Kwok is on the board of Sun Hung Kai Properties Ltd., Asporto Ltd. and Empire Group Holdings Ltd. He received an undergraduate degree from Yale University.
Zen Kwok Pao currently works at Wheelock & Co. Ltd., as Director-External Relations, Harbour Centre Development Ltd., as Non-Executive Director from 2018, Modern Terminals Ltd., as Director, and Wharf Real Estate Investment Co. Ltd., as Director.
Mr. Pao received his undergraduate degree in 1974 from Purdue University.
Currently, Kwok Leung Poon is CFO, Secretary & Executive Director at Blue Moon Group Holdings Ltd. Mr. Poon is also Member of Hong Kong Institute of Certified Public Accountants. Mr. Poon previously held the position of Assistant Manager at KPMG Beijing and Senior Associate at PricewaterhouseCoopers China Ltd. He received an undergraduate degree from the University of Hong Kong and a graduate degree from Tsinghua University School of Law.
Presently, Po Lung Ng occupies the position of Senior Manager-Administration at CK Asset Holdings Ltd.
Ying Lung Chan currently works as a Chief Investment Officer at The Hong Kong & China Gas Co., Ltd.
Founder of Country Garden Holdings Co. Ltd., Kwok Keung Yeung presently is Co-Chairman at this company. He received an undergraduate degree from Jinan University.
Dr. Kwok Po Li is Chairman & Chief Executive Officer at Bank of East Asia Ltd., Chairman & Chief Executive Officer at Bank of East Asia Ltd., Chairman at Insead East Asia Council, Chairman at St. Joseph's College Foundation Ltd., Chairman at The Bank of East Asia (China) Ltd., Chairman at The Chinese Banks Association Ltd., Chairman & President at Legion D'Honneur Club Hong Kong Chapter Association Ltd., Council Member of Employers Federation of Hong Kong, Council Member at Treasury Markets Association, Founder Member at Heung Yee Kuk Foundation Ltd., Founding Chairman at The Friends of Cambridge University in Hong Kong, a Member at Asia Business Council, a Member at Banking Advisory Committee, Non-Executive Chairman at Edelman Asia Pacific, Pro-Chancellor at University of Hong Kong and Vice President-Council at The Hong Kong Institute of Bankers. He is on the Board of Directors at PCCW Ltd., Guangdong Investment Ltd., Vitasoy International Holdings Ltd., San Miguel Brewery HK Ltd., Hongkong & Shanghai Hotels Ltd., Hong Kong & China Gas Co. Ltd., Asian Youth Orchestra, David Li Kwok-Po Charitable Foundation Ltd., Hong Kong Interbank Clearing Ltd., Asia Society, Cambridge Foundation and Institute for Advanced Study, Inc. Dr. Li was previously employed as Non-Executive Director by AFFIN Holdings Bhd., Independent Non-Executive Director by COSCO Pacific Ltd., Independent Non-Executive Director by China Overseas Land & Investment Ltd., Independent Non-Executive Director by Armada Holdings Ltd., Non-Executive Deputy Chairman by Cable & Wireless HKT Ltd., a Member by Legislative Council of Hong Kong, Non-Executive Director by China Merchants China Direct Investments Ltd., Non-Executive Director by Chong Hing Bank Ltd., and Chairman by The Hong Kong Management Association. He also served on the board at CaixaBank SA, Dow Jones & Co., Inc., Chelsfield Partners LLP, The Hong Kong Mortgage Corp. Ltd. and WME IMG LLC.
Wai Wai Kwok is on the board of Edge Case Games Ltd. and Senior Vice President at Kingsoft Corp. Ltd. Mr. Kwok received an undergraduate degree from Saint John University.
Kwok Leung Chu is currently the Chairman of Cathay Pacific Catering Services (H.K.) Ltd., Non-Executive Chairman of Welkin China Private Equity Ltd., Director of John Swire & Sons (H.K.) Ltd., and Director of John Swire & Sons (China) Ltd.
He was formerly the Chairman of AHK Air Hong Kong Ltd., Hong Kong Dragon Airlines Ltd., and John Swire & Sons (China) Ltd.
He was also an Executive Director of Swire Pacific Ltd.
from 2014 to 2020 and a Non-Executive Director of Cathay Pacific Airways Ltd.
from 2017 to 2020.
Additionally, he was a Director of John Swire & Sons Ltd.
Chu received his undergraduate degree from the University of Hong Kong and his graduate degree from The University of New South Wales.
Presently, Kwok Wa Cheung holds the position of Chairman for Kingboard Laminates Holdings Ltd. Mr. Cheung is also on the board of Hallgain Management Ltd., Jamplan (BVI) Ltd., Kingboard Investments Ltd. and Excel First Investments Ltd.
Kai-fai Kwok is Member-Economic Development Commission at Government of Hong Kong Special Administrative Region, Member of All-China Youth Federation, Vice President of The Real Estate Developers Association of Hong Kong and Member of Friends of Hong Kong Association Ltd. and on the board of 5 other companies. He received an undergraduate degree from Stanford University and an MBA from Harvard Business School.
Wen Lung Yen is a businessperson who has been at the head of 5 different companies and is Chairman of CTBC Financial Holding Co., Ltd. and Managing Director at United Real Estate Management Co. Ltd. Mr. Yen is also Chairman at Kainan University and on the board of 9 other companies. Mr. Yen previously occupied the position of Chairman of United Real Estate Management Corp. and Chairman for CTBC Life Insurance Co., Ltd. Mr. Yen received an undergraduate degree from Soochow University.
Mr. Yau Lung Ho is a Chairman at Maple Peak Investments, Inc., a Chairman at Studio City International Holdings Ltd., a Chairman & Chief Executive Officer at Melco Resorts & Entertainment Ltd., a Chairman, Chief Executive Officer & MD at Melco International Development Ltd., a Chairman at Macau International Volunteers Association, a Honorary Patron at Canadian Chamber of Commerce In Macau, a Member at All-China Youth Federation, a Member of Macau Basic Law Promotion Association, a Member-Science & Technology Council of Special Administrative Region of Macau and a Vice Patron at The Community Chest of Hong Kong. He is on the Board of Directors at Melco Leisure & Entertainment Group Ltd., Better Joy Overseas Ltd., Lasting Legend Ltd., Quick Glitter Ltd., The Chinese General Chamber of Commerce, Macau Chamber of Commerce, The Canadian Chamber of Commerce in Hong Kong and The All-China Federation of Industry & Commerce. Mr. Ho was previously employed as a Chairman by Summit Ascent Holdings Ltd., a Chairman by Melco China Resorts (Holding) Ltd., a Chairman by The Chamber of Hong Kong Listed Cos., and a Chairman by Value Convergence Holdings Ltd. He received his undergraduate degree from the University of Toronto.
Currently, May Lung Cha holds the position of Non-Executive Chairman of Hong Kong Exchanges & Clearing Ltd. and Chairman of Hong Kong Stock Exchange (a subsidiary of Hong Kong Exchanges & Clearing Ltd.) and Non-Executive Chairman at The HongKong & Shanghai Banking Corp. Ltd. She is also Member-Executive Council at Government of Hong Kong Special Administrative Region, Member of The State Bar of California and Member of Millstein Center for Corporate Governance & Performance and on the board of 6 other companies. In her past career Ms. Cha held the position of Chairman of Financial Services Development Council. She received an undergraduate degree from the University of Wisconsin and a graduate degree from Santa Clara University.
Lung Chun Wang currently works at Chang Hwa Commercial Bank Ltd., as Head-Information Technology Division from 2021.
Dr. Ping Luen Kwok is a Chairman & Managing Director at Sun Hung Kai Properties Ltd., a Chairman at SUNeVision Holdings Ltd., a Chairman at SmarTone Telecommunications Holdings Ltd., a Chairman at iAdvantage Ltd. and a Council Member at The Chinese University of Hong Kong. He is on the Board of Directors at Transport International Holdings Ltd., Long Win Bus Co. Ltd., Wing Tai Properties Ltd., The Kowloon Motor Bus Co. (1933) Ltd., Cellular 8 Holdings Ltd., Lillie Square GP Ltd., TFS Development Co. Ltd., Wilson Parking New Zealand Ltd. and The Real Estate Developers Association of Hong Kong. Dr. Kwok was previously employed as an Independent Non-Executive Director by Standard Chartered Bank (Hong Kong) Ltd. He received his graduate degree from the University of Cambridge and an MBA from Harvard University.
Founder of Kingboard Holdings Ltd., Kwok Wing Cheung presently is Chairman at this company and Chairman for Nanjing Elec & Eltek Electronic Co. Ltd. (a subsidiary of Kingboard Holdings Ltd.). He is also on the board of Powercom Co., Ltd. and Hallgain Management Ltd. In his past career Mr. Cheung was Chairman at Kingboard Copper Foil Holdings Ltd. and Chairman at Elec & Eltek International Co. Ltd. He received a graduate degree from National Taiwan University of Science & Technology.
Presently, Ngan Yee Lung occupies the position of Finance Director & Executive Director at Swire Properties Ltd. Ms. Lung is also on the board of Brice Manufacturing Co., Inc. and Swire Properties MTN Financing Ltd. In her past career Ms. Lung was Executive Director at Hong Kong Aircraft Engineering Co., Ltd. and Finance Director of Swire Pacific Offshore Holding Ltd.
Kwok Lung Hon is currently the Chairman & Chief Executive Officer at Eterna AG Uhrenfabrik.
He is also the Chairman of Citychamp Watch & Jewellery Group Ltd., Chairman & President of Citichamp (Holdings) Ltd., Director at The Dreyfuss Group Ltd., Director at Rotary Overseas Ltd., and Executive Vice President at China Federation of Overseas Chinese Entrepreneurs.
Previously, he served as the Chairman of Citychamp Dartong Co., Ltd.
from 2001 to 2017.
Fei Lung Kwok worked as an Executive Director at Excelpoint Technology Ltd.
from 2016 to 2021.
He also worked as a Managing Director at Excelpoint Systems (H.K.) Ltd.
Kwok Lung Ho is an Independent Non-Executive Director at Hands Form Holdings Ltd.
since 2019 and a Director & Assistant Project Manager at Chi Sum Engineering Ltd.
since 2016.
He completed his undergraduate degree from Curtin University in 2008.
Yuen Lung Kwok is currently the Chief Human Resources Officer at Baozun, Inc. He previously worked as the Director of the Computer Accessories Department at Philips (China) Investment Co., Ltd.
from 2003 to 2011 and as a Non-Executive Director at Beijing Vastsmart Trading Co. Ltd.
from 2012 to 2014.
Mr. Kwok received his undergraduate degree from Fudan University in 1989.
George KL Hongchoy is currently a trustee at Trustees of the University of Pennsylvania.
Kwok Chuen Kwok currently works at Hong Kong Port Development Council, as Member and Competition Commission (Hong Kong), as Member.
Mr. Kwok also formerly worked at Hong Kong Coalition of Service Industries, as Chairman, SUNeVision Holdings Ltd., as Independent Non-Executive Director from 2012 to 2021, DBS Bank (Hong Kong) Ltd., as Independent Non-Executive Director, The HongKong & Shanghai Banking Corp.
Ltd., as Senior Economist, Standard Chartered Bank (Hong Kong) Ltd., as Regional Chief Economist, HKSAR Government Scholarship Fund, as Member-Aviation Development, and Hong Kong Maritime & Port Board, as Member.
Mr. Kwok received his undergraduate degree and graduate degree from the University of Hong Kong and graduate degree from The Chinese University of Hong Kong.
Lung Chu currently works at Global Unichip (Shanghai) Co., Ltd., as President.
Mr. Chu also formerly worked at Chinese American Semiconductor Professional Association, as Chairman in 2003, Cadence Design Systems, Inc., as President-Asia Pacific Region, Technology Modeling Associates, Inc., as Vice President & General Manager, KLA Corp., as Vice President & General Manager, Magma Design Automation LLC, as Vice President-Asia Pacific Operations, and Global Unichip Corp., as President-China Operations & Vice President from 2009 to 2012.
Mr. Chu received his graduate degree from Case Western Reserve University, graduate degree and Masters Business Admin degree from San Jose State University, and undergraduate degree from National Taiwan University.
Stella Lung currently works as a Senior Manager-Public Relations at Vitasoy International Holdings Ltd.
Mabel L.
Lung is currently a Managing Director at UBS Asset Management (Americas) LLC since 2000.
She holds an MBA from New York University, which she obtained in 1984.
Prior to that, she completed her undergraduate studies at Barnard College in 1981.
Lung Yeh was the founder of ShareVision Technology, Inc. (1991) and Pico Communications, Inc. (1999), where he held the title of Chief Executive Officer.
Currently, he is a Director at Logitech, Inc. Dr. Yeh's former positions include Independent Non-Executive Director at Logitech International SA (2015-2019), Managing Director at Enspire Capital Pte Ltd.
(2004-2015), Vice President-Business Development at Centrality Communications, Inc. (2003-2004), and Vice President-Communication & Internet Division at Creative Labs, Inc. (1993-1998).
Dr. Yeh holds a doctorate from the University of Wisconsin and an undergraduate degree from National Chiao Tung University.
Lung Li has a current job as the Head of Finance Department at Sensortek Technology Corp.
Mervin D.
Lung was the founder who started his career as a Director at Patrick Industries, Inc. in 1959 and held the position until 2005.
Grace Lung currently works at AOPEN, Inc., as Independent Director from 2020.
David Kwok is currently the Chief Financial Officer & Director at Power Group Projects Corp.
and the Chief Financial Officer at RepliCel Life Sciences, Inc. He previously worked as the Chief Financial Officer at Adanac Molybdenum Corp.
from 2005 to 2008.
He also worked as a Divisional Controller at Xstrata Plc, Manager-Business Administration & Controller at Capstone Mining Corp., and Divisional Controller at Glencore Plc from 2010 to 2016.
Additionally, he served as the Chief Financial Officer at Mobilum Technologies, Inc. and as the Chief Financial Officer at Temas Resources Corp.
from 2022 to 2023.
Stephen Kwok has been a Director of SonnenEnergy Corp.
since August 2, 2006.
He has been a Partner of Wong, Kwok and Company LLP since June 2004.
Prior to that, Mr. Kwok was a Partner of H.
Tam and Partners from 1987 to 2004.
He is a Member of the Ontario Institute of Chartered Accountants and Society of Certified Management Accountants of Ontario.
Mr. Kwok received a BCom degree from the University of Toronto and has been practicing public accounting for more than 20 years.
Roger Kwok is currently the Chairman and Independent Non-Executive Director at Vietnam Industrial Investments (Private Equity) since 2007.
He is also currently the Managing Director at Arcadia Group Pty Ltd.
Additionally, Mr. Kwok has previously worked as a Non-Executive Director at Kalgoorlie Mining Co. Ltd.
and as the President at The Western Australian Chinese Chamber of Commerce, Inc.
Wing-Hang Dennis Kwok has held non-executive director positions at The Hong Kong Mortgage Corp.
Ltd.
and Urban Renewal Authority (Hong Kong).
Nancy Kwok is currently working as a Principal & Equities Trader at Connor, Clark & Lunn Investment Management Ltd.
She started this position in 2018.
Prior to her current job, Nancy completed her undergraduate degree at the University of British Columbia in 2002.
Ray Kwok has worked as an Analyst at CGS International Securities Hong Kong Ltd.
since 2004.
Kelvin Kwok has worked as an Analyst at Moody's Investors Service Hong Kong Ltd.
since 2018.
Mike Kwok is currently a member of The Chartered Institute of Logistics & Transport in the UK.
Jeffrey Kwok is a member of the Institution of Mechanical Engineers and the Hong Kong Institution of Engineers.
He previously worked as a Senior Manager-Business Development at Power Assets Investments Ltd.
Mr. Michael Kwok, CFA, is a Principal at Connor, Clark & Lunn Investment Management Ltd.
He is a member of the fundamental equity team, responsible for fundamental research and analysis.
Mr. Kwok was previously employed as an Equity Research Associate by Sanford C.
Bernstein & Co. LLC, an Associate by TD Securities, Inc., and a Teaching Assistant by Queen's University.
He received his Bachelor of Commerce degree from Queen's University (2011) and a Master of Finance degree from Massachusetts Institute of Technology (2014).
Ho Kwok served as the Chief Executive Officer & Executive Director at Hao Tian International Construction Investment Group Ltd.
from 2014 to 2017.
Prior to that, he was the Director-Alumni & Corporate Affairs at The Chinese University of Hong Kong in 2011 and the Marketing Manager at Federal Express (Hong Kong) Ltd.
from 1996 to 2009.
Mr. Kwok earned an undergraduate degree from The Chinese University of Hong Kong in 1992 and an MBA from Rotterdam School of Management in 1996.
No results for this search
- Stock Market
- Advanced search
- Kwok Lung Hongchoy